BCA101
BCA101X1101
Phase 1 small_molecule active
Quick answer
BCA101 for Head and Neck Squamous Cell Carcinoma is a Phase 1 program (small_molecule) at Bicara Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Bicara Therapeutics
- Indication
- Head and Neck Squamous Cell Carcinoma
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- active